Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

2000 Scientific Articles

2000 Immunization Safety Branch Publications:

2000 Peer-Reviewed Journal Articles

  1. Belay ED, Holman RC, Clarke MJ, DeStefano F, Shahriari A, Davis RL, Rhodes PH, Thompson RS, Black SB, Shinefield HR, Marcy SM, Ward JI, Mullooly JP, Chen RT, Schonberger LB. The Incidence of Kawasaki Syndrome in West Coast Health Maintenance Organizations. Ped Infect Dis J; 2000;19:828-32.
  2. Braun MM, Mootrey GT, Salive ME, Chen RT, Ellenberg SS, VAERS Working Group. Infant immunization with acellular pertussis vaccines in the United States: Assessment of the first two years’ data from the Vaccine Adverse Event Reporting System (VAERS). Pediatrics 2000;104(4):e51.
  3. Chen RT, DeStefano F, Davis RL, Jackson LA, Thompson RS, Mulooly JP, Black SB, Shinefield HR, Vadheim CM, Ward JI, Marcy SM, and the Vaccine Datalink Team. The Vaccine Safety Datalink: Immunization research in health maintenance organizations in the USA. Bull WHO 2000;78:186-194.
  4. Chen RT, Hardy IRB, Rhodes PH, Tyshchenko DK, Moiseeva AV, Marievsky VF. Ukraine, 1992: First assessment of diphtheria vaccine effectiveness during the recent resurgence of diphtheria in the former Soviet Union: Introduction. J Infect Dis 2000;181(suppl 1):S178-S183.
  5. Chen RT, Mootrey GT, DeStefano F. Safety of routine childhood vaccinations. An epidemiological review. Pediatric Drugs 2000;2(4):273-290.
  6. Collet JP. MacDonald N. Cashman N. Pless R. Monitoring signals for vaccine safety: the assessment of individual adverse event reports by an expert advisory committee. Advisory Committee on Causality Assessment. Bulletin of the World Health Organization 2000;78(2):178-85.
  7. DeStefano F. Opportunities for population-based clinical research using data from managed care organizations. In: Davis JR, editor. Managed care systems and emerging infections. Washington, DC: National Academy Press, 2000;16-8.
  8. Feikin DR, Lezotte DC, Hamman RF, Salmon DA, Chen RT, Hoffman RE. Excess individual and community risks associated with personal exemptions to immunization: An evaluation of measles and pertussis in Colorado, 1987-1998. JAMA 2000;284:3145-50.
  9. Izurieta HS,Thompson WW, Kramarz P, Shay DK, Davis RL, DeStefano F, Black S, Shinefield H, Fukuda K. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000;342(4):232-239.
  10. Izurieta HS,Thompson WW, Shay DK. Influenza and hospitalizations in children [Letter]. N Engl J Med 2000;342:1753.
  11. Kramarz P, DeStefano F, Gargiullo PM, Davis RL, Chen RT, Mullooly JP, Black SB, Bohlke K, Ward JI, Marcy MS, Okoro CA, Vaccine Safety Datalink Team. Influenza vaccination in children with asthma in health maintenance organizations. Vaccine 2000;18:2288-2294.
  12. Kramarz P, DeStefano F, Gargiullo PM, Davis RL, Chen RT, Mullooly JP, Black SB, Shinefield HR, Bohlke K, Ward JI, Marcy MS, Vaccine Safety Datalink Team. Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Arch Fam Med 2000;9(7):617-623.
  13. Kuppermann M, Nease RF, Ackerson LM, Black SB, Shinefield HR, Lieu TA. Parent preferences for outcomes associated with childhood vaccinations. Pediatr Infect Dis 2000;19:129-133.
  14. Lieu TA, Black SB, Ray GT, Martin KE, Shinefield HR, Weniger BG. The hidden costs of infant vaccination. Vaccine 2000;19:33-41.
  15. Pless R. Vaccination benefits, risks and safety: The need for a complete picture. Bull WHO 2000;78(2):219-221.
  16. Pless R, Risher JF. Mercury, infant neurodevelopment, and vaccination. J Pediatr 2000;136(5):571-573.
  17. Salmon, DA., Gangarosa EJ, Chen RT. Health consequences of exemptions from immunization laws [letter]. JAMA 2000; 283: 1141-2.
  18. Takahashi H. Need for improved vaccine safety surveillance [letter]. Vaccine 2000;19(9-10):1004 [letter]
  19. Takahashi H, Pool V, Tsai TF, Chen RT. Adverse events after Japanese Encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. Vaccine 2000: 18(26), 2963-2969.
  20. Wise RP, Salive ME, Braun MM, Mootrey GT, Seward JF, Rider LG, Krause PR. Post licensure safety surveillance for varicella vaccine. JAMA 2000;284:1271-1279.

2000 Textbook Publications

  1. Barnett ED, Rey M, Chen RT. Vaccine preventable diseases: the commercially available vaccines. In: Dupont HL, Steffen R, eds. Textbook of Travel Medicine and Health, 2nd Edition. Montreal: Decker 2000:232-51.
  2. Chen RT. Special methodological issues in pharmacoepidemiology studies of vaccine safety. In: Strom BL, ed. Pharmacoepidemiology 3rd edition. Sussex: John Wiley & Sons, 2000: 707-732.
  3. Chen RT, Vitek C. Corynebacterial infections. In Kelley WN, ed. Textbook of internal medicine 4th edition. Philadelphia: J B Lippincott, 2000:1984-6.
  4. Kelly WN. The role of pharmacoepidemiology in drug injury and expert testimony. Chapter 11, in: Drug Injury: Liability, Analysis and Prevention. Ed. by James T. O’Donnell. Lawyers & Judges Publishing Company(November 2000).
  5. Terracciano GJ, Chen R. Vaccine safety and adverse events: key issues for health care workers. In: Poland GA, Schaffner W, Pugliese G, eds. Immunizing health care workers: a practical approach. Thorofare, NJ: Slack Inc 2000: 37-60.
 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC–INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #